Background MUC1 is a membrane-tethered mucin expressed on the surface of epithelial and hematopoietic cells. Previous studies have established that MUC1 attenuates airway inflammation in response to Pseudomonas aeruginosa (Pa) through suppression of Toll-like receptor (TLR) signaling. Here, we elucidate the mechanism through which the MUC1 cytoplasmic tail (CT) inhibits TLR5 signaling in response to Pa and its flagellin in primary normal human bronchial epithelial (NHBE) cells. Methods NHBE and human and mouse macrophages were stimulated with Pa or flagellin and transforming growth factor-a (TGF-a) and tumor necrosis factor-a (TNF-a) levels in cell culture supernatants were measured by ELISA. NHBE cells were stimulated with Pa, flagellin, or TNF-a and MUC1-CT, and epidermal growth factor receptor (EGFR) levels were measured by immunoblotting. NHBE cells were stimulated with Pa and MUC1-CT/TLR5 and MUC1-CT/EGFR association were detected by coimmunoprecipitation.
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Background
Pseudomonas aeruginosa (Pa) is a Gram-negative, opportunistic human pathogen responsible for a spectrum of acute and chronic respiratory tract infections. While Pa respiratory tract infection rarely occurs in healthy individuals, patients on mechanical ventilation or undergoing immunosuppression are particularly at risk of nosocomial infection [1] . In these settings, Pa pneumonia is accompanied by excessive airway inflammation with high morbidity and mortality. Pa is also associated with exacerbation of airway disease symptoms, especially in patients with bronchiectasis [2] and chronic obstructive pulmonary disease [3] . In spite of its documented clinical significance, the molecular mechanisms responsible for Pa pathogenesis, and the host response to infection, remain to be elucidated.
Inhaled pathogens are initially trapped by the airway surface liquid and subsequently removed from the airways by the mucociliary clearance process provided by respiratory epithelial cells. Pathogens breaching this first-line of defense are recognized by a family of innate immune receptors expressed by airway epithelial cells and resident leukocytes [4] . Among these receptors, Toll-like receptors (TLRs) play a crucial role in host defence by sensing bacterial components and initiating an innate immune response [4] . TLR5, in particular, recognizes bacterial flagellin, the major protein constituent of flagella, leading to nuclear factor-jB (NF-jB) activation and secretion of proinflammatory cytokines [e.g., tumor necrosis factor-a (TNF-a)] and chemokines [e.g., interleukin-8 (IL-8)] [5] . Supporting the proinflammatory activity of airway epithelia, Pa phagocytosis by alveolar macrophages further contributes to bacterial clearance from the lungs [6] . As with all human pathogens, these innate immune responses against Pa must be closely controlled to maintain homeostasis and prevent disease. For example, hyperactivation of alveolar macrophages by high-dose Pa infection leads to inflammasome activation with excessive production of IL1b and immune cell apoptosis, thus impairing bacterial clearance [7] . Similarly, uncontrolled inflammation in the absence of counter-regulatory mechanisms may cause detrimental, bystander damage to host tissues [7] .
We previously reported that the transmembrane mucin, MUC1 (MUC1 in humans, Muc1 in animals), plays an anti-inflammatory role during Pa lung infection [8] [9] [10] [11] . MUC1 consists of two noncovalently associated subunits, a [250 kDa ectodomain containing a variable number of highly glycosylated tandem repeats, and a 25 kDa intracellular, tyrosine-phosphorylated cytoplasmic tail (CT) [12, 13] . The MUC1 heterodimer is expressed on the apical surface of mucosal epithelial cells and hematopoietic cells [12] . In mice, Muc1 expression inhibited ligand-specific TLR activation in both airway epithelial cells and alveolar macrophages [14] . Although Muc1 expression levels are low in uninfected mouse lungs, Pa airway infection induced a dramatic increase in its expression in a TNF-a-dependent manner [15] . Our recent studies with human A549 lung adenocarcinoma cells demonstrated that TGF-a-induced EGFR activation stimulated MUC1-CT tyrosine phosphorylation and increased MUC1-CT/TLR5 interaction, resulting in decreased TLR5/MyD88 association, diminished TLR5-dependent signaling, and attenuated inflammation [11] . However, since transformed and tumor-derived epithelial cells often display abnormal biochemical and physiologic responses, the current study was undertaken to assess Pastimulated EGFR activation, MUC1-CT tyrosine phosphorylation, and MUC1-CT/TLR5 association using primary NHBE cells.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. The sources of antibodies were mouse monoclonal anti-phosphotyrosine antibody (P-Tyr-100), rabbit monoclonal anti-EGFR antibody (D38B1), and rabbit monoclonal anti-phospho-EGFR (Tyr1068) antibody (D7A5) ( [16] . Human alveolar macrophages were isolated by centrifugation of bronchoalveolar lavage fluid from healthy adult volunteers using a protocol approved by the University of Arizona College of Medicine Institutional Review Board. Bone marrow cells were harvested from the femurs and tibias of C57BL6/J mice, and peritoneal macrophages were isolated from thioglycolate-treated C57BL6/J mice as described [17] using a protocol approved by the University of Arizona Collage of Medicine Institutional Animal Care and Use Committee. Bone marrow cells were cultured for 7 days with 10 ng/ml of murine macrophagecolony stimulating factor (R&D Systems) to induce macrophage differentiation. THP-1 cells and murine macrophages were seeded at 2.5 9 10 6 cells/well in 6-well plates, and human alveolar macrophages were seeded at 5.0 9 10 5 cells/well in 24-well plates, and cultured in RPMI-1640 containing 2.0 mM glutamine, 1.0 mM sodium pyruvate, 100 U/ml penicillin, 100 lg/ml streptomycin and 10 % FBS at 37°C in a humidified incubator containing 5 % CO 2 in air.
Stimulation of NHBE cells and macrophages with heat-inactivated Pa and purified flagellin
Heat-inactivated Pa strain K (PAK) was prepared by incubating 1.0 9 10 9 colony forming units (CFU)/ml of bacteria at 60°C for 30 min and stored at -80°C as described [11] . NHBE cells and macrophages were washed twice with DPBS, pre-incubated in Opti-MEM (Life Technologies) for 2 h, and stimulated with 1.0 9 10 6 , 1.0 9 10 7 , or 1.0 9 10 8 CFU/ml of heat-inactivated PAK or 100 ng/ml of purified Pa flagellin (FLA-PA Ultrapure, InvivoGen, San Diego, CA, USA) as described [11] .
ELISA
Human TGF-a, and human and mouse TNF-a, were quantified in cell culture supernatants by enzyme-linked immunosorbent assay (ELISA) using biotinylated detection antibodies (R&D Systems; eBioscience, San Diego, CA, USA) and HRP-labeled streptavidin (KPL, Gaithersburg, MD, USA). A standard curve for each protein was generated for each ELISA plate.
Immunoblot and co-immunoprecipitation analyses
Immunoblot and immunoprecipitation were performed as described previously [11] . The EGFR immunoprecipitates were processed for immunoblotting with antibodies to phospho-EGFR (Tyr1068) and the MUC1-CT immunoprecipitates were processed for immunoblotting with antibodies to phosphotyrosine, TLR5, or EGFR. To control for protein loading and transfer, the blots were stripped and reprobed with the immunoprecipitating antibody.
Statistical analysis
Values were expressed as mean ± SEM. Differences between means were compared using the Student's t test and considered significant if p \ 0.05.
Results
Pa and flagellin stimulate release of TGF-a from NHBE cells Yu et al. [18] previously reported that treatment of 16HBE cells, a SV40 transformed human bronchial epithelial cell line, with Pa flagellin-stimulated TGF-a release, EGFR tyrosine phosphorylation, and MUC5AC expression in a TNF-a converting enzyme (TACE)-dependent manner. We asked whether stimulation of primary NHBE cells by Pa and/or its flagellin might also induce TGF-a release and EGFR tyrosine phosphorylation. Treatment of NHBE cells with 1.0 9 10 7 CFU/ml of heat-inactivated PAK or 100 ng/ml of flagellin for 1, 6, or 24 h increased TGF-a levels in cell culture supernatants (Fig. 1a, b) , and increased EGFR tyrosine phosphorylation (Fig. 1c, d ), compared with unstimulated controls. Flagellin stimulation in the presence of the EGFR selective inhibitor, AG1478, abrogated EGFR tyrosine phosphorylation (Fig. 1d) . Zhang et al. previously reported that heat-inactivated PAK mediates cytokine release from human airway epithelial cells through activation of TLR5 by its flagellin [5] . Thus, in the present study, we used heat-inactivated PAK and flagellin interchangeably in stimulating TLR5 signaling.
Pa and flagellin elicit TNF-a release from primary macrophages, but not NHBE cells Our previous in vivo and in vitro studies demonstrated that TNF-a, another proinflammatory cytokine generated by TACE, up-regulates MUC1/Muc1 expression in human A549 cells [19] and Pa-infected mouse lungs [15, 19] . Since A549 cells are a lung adenocarcinoma cell line, we tested whether stimulation of primary NHBE cells by Pa or flagellin also induce TNF-a release. The levels of TNF-a in culture supernatants of Pa-or flagellin-stimulated NHBE cells were undetected by ELISA over the course of 24 h (data not shown). On the other hand, stimulation of human alveolar macrophages increased TNF-a levels in cell culture supernatants in a dose-dependent manner (Fig. 2a) . Identical results were seen in other macrophages such as human THP-1-derived macrophages (Fig. 2b) , mouse peritoneal macrophages (Fig. 2c) , and mouse bone marrow-derived macrophages (Fig. 2d) . These results are consistent with a recent report that, whereas Pa or flagellin elicited TNF-a release by mouse alveolar macrophages, treatment of mouse primary airway epithelial cells by either stimulus failed to stimulate TNF-a release [20] .
Exogenous TNF-a, but not Pa, up-regulates MUC1 expression in NHBE cells
To directly assess the ability of Pa or TNF-a to up-regulate MUC1 expression, NHBE cells were stimulated for 24 h with 1.0 9 10 7 or 1.0 9 10 8 CFU/ml of heat-inactivated PAK, 50 ng/ml of human recombinant TNF-a, or medium controls and cell lysates were probed on immunoblots for MUC1-CT and EGFR. Whereas Pa failed to alter MUC1-CT expression, TNF-a stimulation increased both MUC1-CT and EGFR expression (Fig. 3) . Similarly, Pa failed to up-regulate Muc1 expression in differentiated, primary mouse airway epithetical cells (data now shown).
Pa stimulation of NHBE cells increases tyrosine phosphorylation of MUC1-CT and augments MUC1-CT/TLR5 and MUC1-CT/EGFR association
The MUC1-CT interacts with EGFR and EGFR tyrosine phosphorylates MUC1-CT at a Tyr-Glu-Lys-Val motif in breast adenocarcinoma cells [21] [22] [23] . Further, tyrosinephosphorylated MUC1-CT associates with TLR5 in lung cancer cells [11] . We asked whether Pa stimulation of primary NHBE cells, which activates EGFR (Fig. 1c) , might increase MUC1-CT tyrosine phosphorylation and MUC1-CT association with TLR5 and/or EGFR. NHBE cells were pretreated for 24 h with 50 ng/ml of TNF-a, following which the cells were washed and either unstimulated or stimulated for increasing times with 1.0 9 10 8 CFU/ml of heat-inactivated PAK. Cell lysates were subjected to MUC1-CT immunoprecipitation and the immunoprecipitates processed for phosphotyrosine, TLR5, or EGFR immunoblotting. Pa stimulation of NHBE cells increased MUC1-CT tyrosine phosphorylation (Fig. 4a,  upper panel) . When each MUC1-CT phosphotyrosine densitometry signal was normalized to the total MUC1-CT signal (Fig. 4a, lower blot, Pa stimulation for 0.5, 1, and 6 h increased MUC1-CT tyrosine phosphorylation by 1.5-, 3.7-, and 4.0-fold, respectively, compared with unstimulated controls (Fig. 4b) . Pa stimulation of NHBE cells also augmented MUC1-CT/TLR5 co-immunoprecipitation (Fig. 4, middle  panel) . Densitometric analysis revealed 1.7-and 1.8-fold increased MUC1-CT/TLR5 association following 1 and 6 h Pa stimulation compared with unstimulated controls (Fig. 4c) . In other experiments, Pa stimulation of NHBE cells for 1 h increased MUC1-CT/TLR5 association by 1.4-fold and MUC1-CT/EGFR association by 2.3-fold compared with medium controls (Fig. 4d-f) . Finally, Pa stimulation for 1 h in the presence of AG1478 protected against Pa-stimulated increases in both MUC1-CT/TLR5 and MUC1-CT/EGFR association (Fig. 4d-f) . As negative controls, neither MUC1-CT tyrosine phosphorylation, nor MUC1-CT/TLR5 or MUC1-CT/EGFR co-immunoprecipitation, were seen using lysates of NHBE cells stimulated with Pa when normal Armenian hamster IgG was used in lieu of the MUC1-CT immunoprecipitating antibody (Fig. 4a, d ). Taken together, these data indicate that Pa stimulation of primary NHBE cells increases MUC1-CT tyrosine phosphorylation and enhances MUC1-CT association with both TLR5 and EGFR.
Discussion
MUC1/Muc1 expression attenuates airway inflammation during Pa lung infection [8, 19] and following intranasal challenge with Pa flagellin [8] . This anti-inflammatory activity has been ascribed to the ability of MUC1/Muc1 to inhibit TLR signaling [8, 9, 14] . However, the mechanistic details of this counter-regulatory effect remain to be elucidated. In this report, we now demonstrate that stimulation of primary NHBE cells with Pa or flagellin increased the release of TGF-a, but not TNF-a, from NHBE cells. This is in contrast to our previous reports in which treatment of A549 lung adenocarcinoma cells with pathogens stimulated TNF-a release which resulted in MUC1 upregulation in an autocrine fashion [24, 25] . Pa/flagellin-stimulated TGF-a release led to activation of its cognate cell surface receptor, EGFR, in NHEB cells. By contrast, Pa stimulation of human or mouse macrophages enhanced TNF-a release, and stimulation of NHBE cells with exogenous, recombinant TNF-a increased both MUC1-CT and EGFR protein levels. Finally, immunoprecipitation experiments established that Pa stimulation enhanced MUC1-CT tyrosine phosphorylation, and increased MUC1-CT/TLR5 and MUC1-CT/EGFR protein association. Because both alveolar macrophages and NHBE cells express pattern recognition receptors (e.g., TLRs) [20] , these results suggest a mechanism whereby inhaled Pa activate alveolar macrophages to release TNF-a, which in turn, increases MUC1 expression by NHBE cells in a paracrine fashion, while Pa stimulation of airway epithelial cells promotes TGF-a release, autocrine EGFR activation, MUC1-CT tyrosine phosphorylation, and MUC1-CT/TLR5 association (Fig. 5) . Based on our studies in HEK293 and A549 cells [11] , we further propose that increased MUC1-CT/ TLR5 association in NHBE cells diminishes Pa-and flagellin-driven, TLR5-dependent intracellular signaling and downstream inflammatory responses (Fig. 5) .
EGFR regulates mucin secretion by airway goblet cells [26] . Mechanistic studies revealed that Pa bacterial supernatants induce mucin production in human NCI-H292 airway epithelial cells through activation of TACE, release of TGF-a, and autocrine EGFR phosphorylation [27, 28] . TGF-a is initially synthesized as a membranebound protein on the surface of airway epithelial cells. TACE proteolytically cleavages pro-TGF-a to the active ligand that engages EGFR, inducing its autotransactivation and proinflammatory signaling [29] . The current study now demonstrates a second effect of Pa-stimulated EGFR activation in normal airway epithelia, i.e., MUC1-CT tyrosine phosphorylation and MUC1-CT/TLR5 association. These observations support prior reports showing EGFR tyrosine phosphorylates MUC1-CT in breast cancer cells [21] , and that tyrosine-phosphorylated MUC1-CT interacts with TLR5 in lung cancer cells [11] . Recently, suppression of TLR5-dependent proinflammatory responses by MUC1 also has been documented in telomerase-transformed, immortalized human corneal epithelial cells [30] , MNK7 human gastric cancer cells [31] , and murine dendritic cells [32] . To our knowledge, however, this is the first report demonstrating both EGFRdriven MUC1-CT phosphorylation and MUC1-CT/TLR5 association in nontransformed, normal human airway epithelial cells.
While TLR activation is an essential defense mechanism, it must be tightly regulated by counter-balancing, anti-inflammatory pathways in order to prevent the development of autoimmune and hyper-inflammatory diseases. Three major anti-inflammatory mechanisms downregulating TLR-driven inflammation have been described, dissociation of adaptor molecules, degradation of signaling proteins, and decreased gene transcription [33] . We previously reported that Muc1 knockout mice exhibit greater airway inflammation following Pa lung infection compared with Muc1-expressing littermates [8] . Subsequently, we demonstrated that overexpression of the full-length MUC1, but not a deletion mutant lacking the MUC1-CT, attenuated in vitro proinflammatory responses, thus mapping the anti-inflammatory effect to its intracellular domain [14] .
The results of the current study, and those reported elsewhere [11] , now indicate that tyrosine phosphorylation of the MUC1-CT enhances its association with TLR5, thereby competitively inhibiting recruitment of the TLR adapter protein, MyD88, to TLR5, which is an additional anti-inflammatory mechanism down-regulating TLR-driven inflammation.
The observation that MUC1-CT also associates with EGFR in primary NHBE cells confirms previous reports of MUC1-CT/EGFR interaction in breast adenocarcinoma cells [21] [22] [23] . Cross-talk between MUC1 and EGFR has been demonstrated in various cellular contexts. Anti-MUC1 antibody was shown to inhibit EGFR signaling [34] , and targeting the MUC1-CT with a peptide that blocks its homodimerization diminished EGFR activation [35] . Activated EGFR stimulated MUC1 expression [36] , and suppression of MUC1 synthesis down-regulated EGFR expression [37] . In the airways, MUC1 contributed to human bronchial epithelial cell transformation through facilitating EGFR activation [38] . These examples of crosstalk between MUC1 and EGFR might be regulated, in part, through their molecular interaction. Whether MUC1-CT forms a protein complex with EGFR simultaneous with or independent of TLR5, and whether MUC1-CT association with TLR5 might influence MUC1-EGFR cross-talk (and vice versa), are currently unknown.
Conclusions
Stimulation of primary NHBE cells with the opportunistic human pathogen, Pa, or its flagellin, induces EGFR association with and tyrosine phosphorylation of the MUC1-CT. MUC1-CT tyrosine phosphorylation increases its association with TLR5. Based on other studies in lung adenocarcinoma cells [11] , increased MUC1-CT/TLR5 association in NHBE cells is predicted to competitively inhibit Pa-or flagellin-stimulated TLR5 activation, reduce TLR5-dependent cell signaling, and diminish airway inflammatory responses.
